Sara Moccia

Dr. Sara Moccia

Department of Information Engineering, Università Politecnica delle Marche, Ancona, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
Sara MocciaSara Moccia
Sara Moccia
EMElena De Momi
Elena De Momi
SHSara El Hadji
Sara El Hadji
Leonardo S. MattosLeonardo S. Mattos
Leonardo S. Mattos

15 May 2019 in IEEE Robotics and Automation Letters
Verified
Journal Article
Closed access
ECEmanuele Colleoni
Emanuele Colleoni
Sara MocciaSara Moccia
Sara Moccia
XDXiaofei Du
Xiaofei Du
EMElena De Momi
Elena De Momi
DSDanail Stoyanov
Danail Stoyanov
Surgical-tool detection from laparoscopic images is an important but challenging task in computer-assisted minimally invasive surgery. Illumination levels, variations in background and the different number of tools in the field of view, all pose difficulties to algorithm and model training. Yet, such challenges could be potentially tackled by exploiting the temporal information in laparoscopic videos to avoid per frame handling of the problem. In this paper, we propose a novel encoder- decoder architecture for surgical instrument detection and ar- ticulation joint detection that uses 3D convolutional layers to exploit spatio-temporal features from laparoscopic videos. When tested on benchmark and custom-built datasets, a median Dice similarity coefficient of 85.1% with an interquartile range of 4.6% highlights performance better than the state of the art based on single-frame processing. Alongside novelty of the network architecture, the idea for inclusion of temporal information appears to be particularly useful when processing images with unseen backgrounds during the training phase, which indicates that spatio-temporal features for joint detection help to generalize the solution.

20 November 2018 in Magnetic Resonance Materials in Physics, Biology and Medicine
Verified
Journal Article
Closed access
PDF file
Sara MocciaSara Moccia
Sara Moccia
RBRiccardo Banali
Riccardo Banali
Chiara MartiniChiara Martini
Chiara Martini
GMGiuseppe Muscogiuri
Giuseppe Muscogiuri
Gianluca PontoneGianluca Pontone
Gianluca Pontone
Enrico Gianluca CaianiEnrico Gianluca Caiani
Enrico Gianluca Caiani

22 October 2021 in Journal of Intensive Medicine
Verified
Journal Article
Open access
JMJonathan Montomoli
Jonathan Montomoli
LRLuca Romeo
Luca Romeo
Sara MocciaSara Moccia
Sara Moccia
MBMichele Bernardini
Michele Bernardini
LMLucia Migliorelli
Lucia Migliorelli
MAMario Alfaro-Farias
Mario Alfaro-Farias
Accurate risk stratification of critically ill patients with coronavirus disease 2019 (COVID-19) is essential for optimizing resource allocation, delivering targeted interventions, and maximizing patient survival probability. Machine learning (ML) techniques are attracting increased interest for the development of prediction models as they excel in the analysis of complex signals in data-rich environments such as critical care. We retrieved data on patients with COVID-19 admitted to an intensive care unit (ICU) between March and October 2020 from the RIsk Stratification in COVID-19 patients in the Intensive Care Unit (RISC-19-ICU) registry. We applied the Extreme Gradient Boosting (XGBoost) algorithm to the data to predict as a binary outcome the increase or decrease in patients’ Sequential Organ Failure Assessment (SOFA) score on day 5 after ICU admission. The model was iteratively cross-validated in different subsets of the study cohort. The final study population consisted of 675 patients. The XGBoost model correctly predicted a decrease in SOFA score in 320/385 (83%) critically ill COVID-19 patients, and an increase in the score in 210/290 (72%) patients. The area under the mean receiver operating characteristic curve for XGBoost was significantly higher than that for the logistic regression model (0.86 vs. 0.69, P < 0.01 [paired t-test with 95% confidence interval]). The XGBoost model predicted the change in SOFA score in critically ill COVID-19 patients admitted to the ICU and can guide clinical decision support systems (CDSSs) aimed at optimizing available resources.

29 June 2020 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
PZPaolo Zaffino
Paolo Zaffino
Sara MocciaSara Moccia
Sara Moccia
EMElena De Momi
Elena De Momi
MSMaria Francesca Spadea
Maria Francesca Spadea

3 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MRMarco Riva
Marco Riva
TSTommaso Sciortino
Tommaso Sciortino
RSRiccardo Secoli
Riccardo Secoli
EDEster D’amico
Ester D’amico
Sara MocciaSara Moccia
Sara Moccia
LBLorenzo Bello
Lorenzo Bello
Identifying tumor cells infiltrating normal-appearing brain tissue is critical to achieve a total glioma resection. Raman spectroscopy (RS) is an optical technique with potential for real-time glioma detection. Most RS reports are based on formalin-fixed or frozen samples, with only a few studies deployed on fresh untreated tissue. We aimed to probe RS on untreated brain biopsies exploring novel Raman bands useful in distinguishing glioma and normal brain tissue. Sixty-three fresh tissue biopsies were analyzed within few minutes after resection. A total of 3450 spectra were collected, with 1377 labelled as Healthy and 2073 as Tumor. Machine learning methods were used to classify spectra compared to the histo-pathological standard. The algorithms extracted information from 60 different Raman peaks identified as the most representative among 135 peaks screened. We were able to distinguish between tumor and healthy brain tissue with accuracy and precision of 83% and 82%, respectively. We identified 19 new Raman shifts with known biological significance. Raman spectroscopy was effective and accurate in discriminating glioma tissue from healthy brain ex-vivo in fresh samples. This study added new spectroscopic data that can contribute to further develop Raman Spectroscopy as an intraoperative tool for in-vivo glioma detection.